The recent arrival of Tirzepatide 40mg represents a potentially revolutionary advancement in the treatment of type 2 the condition . This therapy builds upon the established success of lower dosages , showing promising results in reducing blood glucose readings and supporting weight loss . Experts are exploring its overall impact on heart outcomes